Alleviant Medical

About:

Alleviant Medical develops transcatheter technology designed to lift the clinical and economic burden of heart failure.

Website: https://www.alleviantmedical.com

Twitter/X: alleviant

Top Investors: S3 Ventures, TMC Venture Fund, Vensana Capital, Broadview Ventures, Shangbay Capital

Description:

Alleviant Medical focuses on developing a minimally-invasive medical device to treat congestive heart failure. Its proprietary transcatheter technology is designed to create a paradigm shift in the treatment of heart failure by relieving patient symptoms, improving quality of life, and reducing hospital readmissions for over 6 million Americans currently suffering from this disease.

Total Funding Amount:

$86.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2017-02-01

Contact Email:

info(AT)alleviantmedical.com

Founders:

Albertien Greijdanus, Avni Patel, Jacob Kriegel, na na

Number of Employees:

11-50

Last Funding Date:

2023-01-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai